We are live on ! Find out more
FLGT icon

Fulgent Genetics

16 hedge funds and large institutions have $7.55M invested in Fulgent Genetics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more capital invested

Capital invested by funds: $3.84M → $7.55M (+$3.71M)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

7% more funds holding

Funds holding: 1516 (+1)

0.11% more ownership

Funds ownership: 6.7%6.81% (+0.11%)

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

FLGT Hedge Fund Activity: Q1 2019 in Review

16 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q1 2019, worth a combined $7.55M — up 97% from $3.84M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new FLGT positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $120K. The largest seller was Mutual Advisors, cutting an estimated $67.9K.

  • 16 institutional investors held Fulgent Genetics (FLGT) as of Q1 2019, up from 15 in Q4 2018.
  • Funds reported $7.55M of Fulgent Genetics stock for Q1 2019, up 97% quarter-over-quarter.
  • 3 funds opened new Fulgent Genetics positions in Q1 2019 and 2 closed out, a net change of +1 holder.
  • The largest Fulgent Genetics buyer in Q1 2019 was Renaissance Technologies, an estimated $120K added.
  • The largest Fulgent Genetics seller in Q1 2019 was Mutual Advisors, an estimated $67.9K sold.

Based on aggregated 13F filings for Q1 2019.